Vimarsana
Biggest News Aggregation in the World

Ivan Oransky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ivan Oransky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ivan Oransky Today - Breaking & Trending Today

F.D. Flam: Fake scientific studies are a problem that's getting harder to solve – Twin Cities - Vimarsana News

F.D. Flam: Fake scientific studies are a problem that's getting harder to solve – Twin Cities

Faking it until you make it may be a common practice in some careers. But it's clearly unethical for scientists and medical researchers.

Opinion: Fake scientific studies are a problem that's getting harder to solve - Vimarsana News

Opinion: Fake scientific studies are a problem that's getting harder to solve

Faking it until you make it may be a common practice in some careers. But it's clearly unethical for scientists and medical researchers.

F.D. Flam: Fake scientific studies are a problem that's getting harder to solve – Hartford Courant - Vimarsana News

F.D. Flam: Fake scientific studies are a problem that's getting harder to solve – Hartford Courant

Faking it until you make it may be a common practice in some careers. But it’s clearly unethical for scientists and medical researchers. All the same thousands of fake papers are churned out by so-called paper mills and published every year, many of them in peer-reviewed journals. The issue made headlines recently when Wiley, a respected publishing house, announced it would be dropping 19 of ...

Fake scientific studies are a problem that's getting harder to solve - Vimarsana News

Fake scientific studies are a problem that's getting harder to solve

These aren't just papers with fudged data -- they're fake all the way through.

Star USC scientist faces scrutiny — retracted papers and a paused drug trial - Vimarsana News

Star USC scientist faces scrutiny — retracted papers and a paused drug trial

A group of whistle-blowers submitted a report to the NIH that questioned the integrity of a celebrated neuroscientist's research and the safety of an experimental stroke treatment his company was developing.